New Stock News | Zhiyuan Pharmaceutical Submits Application to Hong Kong Stock Exchange

According to the Hong Kong Stock Exchange disclosure on July 9th, Jiangsu Zhiyuan Pharmaceutical Co., Ltd. (referred to as Zhiyuan Pharmaceutical) has submitted its listing application to the Hong Kong Stock Exchange main board, with CITIC SEC as its sole sponsor. According to the prospectus, the company is a Chinese pharmaceutical company focusing on the field of dermatology, with leading products in multiple treatment areas, providing a comprehensive solution covering skin medications and medical-grade skincare products from head to toe.